Skip to main content

Advertisement

Log in

The epidemiology of hepatitis C infection in the United States

  • Review
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The prevalence of hepatitis C virus (HCV) infection in the United States has remained constant from 1988 through 2002, although the peak age of infection has increased. While the number of new HCV cases is declining, the rates of HCV-associated morbidity and mortality are increasing. We reviewed the risk factors for HCV infection, the laboratory methods used to diagnose it, the dynamics of disease progression, and the natural history of HCV infection.

Methods

Medline searches were performed using the key word HCV, together with incidence, risk factors, demographics, diagnostic methods, disease progression, natural history, normal alanine aminotransferase (ALT), fibrosis, and hepatocellular carcinoma (HCC).

Results

Three characteristics—abnormal serum ALT, history of injection drug use, and blood transfusion before 1992—identified 85% of HCV-positive individuals 20–59 years old. About 75%–85% of acutely infected individuals progress to chronic infection, with up to 20% developing liver cirrhosis over 20–25 years, putting them at increased risk for end-stage liver disease and/or HCC. HCV-associated cirrhosis is the leading cause of liver transplantation in the United States. Rates of infection are higher in non-Hispanic blacks than in non-Hispanic whites and Mexican Americans and higher in men than in women. In the United States, over 70% of HCV-infected individuals are infected with genotype 1.

Conclusions

HCV infection is more prevalent than human immunodeficiency virus or hepatitis B virus infection and is particularly common among certain demographic groups. Individual rates of fibrosis progression vary, but identification of host and viral characteristics associated with disease progression may reveal the mechanisms of HCV-associated hepatic fibrosis/cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E Szabó G Lotz C Páska A Kiss Z Schaff (2003) ArticleTitleViral hepatitis: new data on hepatitis C infection Pathol Oncol Res 9 215–21 Occurrence Handle14688826

    PubMed  Google Scholar 

  2. MJ Alter D Kruszon-Moran OV Nainan G McQuillan F Gao L Moyer et al. (1999) ArticleTitleThe prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 556–62 Occurrence Handle10451460 Occurrence Handle10.1056/NEJM199908193410802 Occurrence Handle1:STN:280:DyaK1Mzmt1Whsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  3. GL Armstrong A Wasley EP Simard GM McQuillan WL Kuhnert MJ Alter (2006) ArticleTitleThe prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 705–14 Occurrence Handle16702586

    PubMed  Google Scholar 

  4. TM Hammett MP Harmon W Rhodes (2002) ArticleTitleThe burden of infectious disease among inmates of and releasees from US correctional facilities, 1997 Am J Public Health 92 1789–94 Occurrence Handle12406810

    PubMed  Google Scholar 

  5. Harrison PM, Beck AJ. Prisoners in 2004. Bureau of Justice Statistics Bulletin. Available at: http://www.ojp.usdoj.gov/bjs/abstract/p04.htm. Accessed 14 December 2005

  6. U.S.Department of Justice. Corrections statistics. Available at: http://www.ojp.usdoj.gov/bjs/correct.htm. Accessed 14 December 2005

  7. C Weinbaum R Lyerla HS Margolis (2003) ArticleTitlePrevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention MMWR Recomm Rep 52 IssueIDRR-1 1–36 Occurrence Handle12562146

    PubMed  Google Scholar 

  8. L Solomon C Flynn K Muck J Vertefeuille (2004) ArticleTitlePrevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities J Urban Health 81 25–37 Occurrence Handle15047781

    PubMed  Google Scholar 

  9. G Gamache R Rosenheck R Tessler (2001) ArticleTitleThe proportion of veterans among homeless men: a decade later Soc Psychiatry Psychiatr Epidemiol 36 481–5 Occurrence Handle11768845 Occurrence Handle10.1007/s001270170012 Occurrence Handle1:STN:280:DC%2BD38%2Fkt1ykug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. RA Desai RA Rosenheck V Agnello (2003) ArticleTitlePrevalence of hepatitis C virus infection in a sample of homeless veterans Soc Psychiatry Psychiatr Epidemiol 38 396–401 Occurrence Handle12861447

    PubMed  Google Scholar 

  11. ME Briggs C Baker R Hall JM Gaziano D Gagnon N Bzowej et al. (2001) ArticleTitlePrevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center Hepatology 34 1200–5 Occurrence Handle11732010 Occurrence Handle10.1053/jhep.2001.29303 Occurrence Handle1:STN:280:DC%2BD3MnosV2qsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  12. G Mishra C Sninsky R Roswell S Fitzwilliam KC Hyams (2003) ArticleTitleRisk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital Dig Dis Sci 48 815–20 Occurrence Handle12741477 Occurrence Handle10.1023/A:1022865515735

    Article  PubMed  Google Scholar 

  13. KL Sloan KA Straits-Tröster JA Dominitz DR Kivlahan (2004) ArticleTitleHepatitis C tested prevalence and comorbidities among veterans in the US Northwest J Clin Gastroenterol 38 279–84 Occurrence Handle15128077 Occurrence Handle10.1097/00004836-200403000-00016

    Article  PubMed  Google Scholar 

  14. J Rakela HE Vargas (2002) ArticleTitleHepatitis C: magnitude of the problem Liver Transpl 8 S3–S6 Occurrence Handle12362291 Occurrence Handle10.1053/jlts.2002.35855

    Article  PubMed  Google Scholar 

  15. InstitutionalAuthorNameNational Institutes of Health (2002) ArticleTitleManagement of hepatitis C: 2002 NIH Consensus Statement 19 1–46

    Google Scholar 

  16. DB Strader T Wright DL Thomas LB Seeff (2004) ArticleTitleAmerican Association for the Study of Liver Diseases practice guideline: diagnosis, management, and treatment of hepatitis C Hepatology 39 1147–71 Occurrence Handle15057920 Occurrence Handle10.1002/hep.20119

    Article  PubMed  Google Scholar 

  17. JH Hoofnagle C Hepatitis (1997) ArticleTitlethe clinical spectrum of disease Hepatology 26 IssueIDSuppl 1 15S–20S Occurrence Handle9305658 Occurrence Handle10.1002/hep.510260703 Occurrence Handle1:STN:280:DyaK2svkvFWruw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  18. PJ Pockros (2002) ArticleTitleDevelopments in the treatment of chronic hepatitis C Expert Opin Investig Drugs 11 515–28 Occurrence Handle11922860 Occurrence Handle10.1517/13543784.11.4.515 Occurrence Handle1:CAS:528:DC%2BD38XjtFKhtL4%3D

    Article  PubMed  CAS  Google Scholar 

  19. M Shiffman AM Di Bisceglie KL Lindsay C Morishima EC Wright GT Everson et al. (2004) ArticleTitleand the HALT-C Trial Group. Peginterferon alpha-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment Gastroenterology 126 1015–23 Occurrence Handle15057741 Occurrence Handle10.1053/j.gastro.2004.01.014 Occurrence Handle1:CAS:528:DC%2BD2cXkt1Krsbc%3D

    Article  PubMed  CAS  Google Scholar 

  20. Centers for Disease Control. Disease burden from hepatitis A, B, and C in the United States. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/dz_burden.htm. Accessed 10 February 2006

  21. MJ Alter (1997) ArticleTitleEpidemiology of hepatitis C Hepatology 26 IssueIDSuppl 1 62S–5S Occurrence Handle9305666 Occurrence Handle10.1002/hep.510260711 Occurrence Handle1:STN:280:DyaK2svkvFWqtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  22. JB Wong GM McQuillan JG McHutchison T Poynard (2000) ArticleTitleEstimating future hepatitis C morbidity, mortality, and costs in the United States Am J Public Health 90 1562–9 Occurrence Handle11029989 Occurrence Handle1:STN:280:DC%2BD3cvnvFWnuw%3D%3D Occurrence Handle10.2105/AJPH.90.10.1562

    Article  PubMed  CAS  Google Scholar 

  23. SD Ryder WL Irving DA Jones KR Neal J Underwood (2004) ArticleTitleC, on behalf of the Trent Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study Gut 53 451–5 Occurrence Handle14960533 Occurrence Handle10.1136/gut.2003.021691 Occurrence Handle1:STN:280:DC%2BD2c%2Fnt1Whug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  24. WR Kim (2002) ArticleTitleThe burden of hepatitis C in the United States Hepatology 36 S30–S34 Occurrence Handle12407574 Occurrence Handle10.1002/hep.1840360705

    Article  PubMed  Google Scholar 

  25. L Benvegnü M Gios S Boccato A Alberti (2004) ArticleTitleNatural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications Gut 53 744–9 Occurrence Handle15082595 Occurrence Handle10.1136/gut.2003.020263

    Article  PubMed  Google Scholar 

  26. G Dal Molin C Tiribelli C Campello (2003) ArticleTitleA rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection Ann Hepatol 2 76–83 Occurrence Handle15041895

    PubMed  Google Scholar 

  27. J-M Pawlotsky (2003) ArticleTitleDiagnostic testing in hepatitis C virus infection: viral kinetics and genomics Semin Liver Dis 23 IssueIDSuppl 1 3–11 Occurrence Handle12934162

    PubMed  Google Scholar 

  28. J-M Pawlotsky I Lonjon C Hezode B Raynard F Darthuy J Remire et al. (1998) ArticleTitleWhat strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 27 1700–2 Occurrence Handle9620345 Occurrence Handle10.1002/hep.510270632 Occurrence Handle1:STN:280:DyaK1c3otFKmtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  29. MJ Alter WL Kuhnert L Finelli (2003) ArticleTitleGuidelines for laboratory testing and result reporting of antibody to hepatitis C virus MMWR Recomm Rep 52 IssueIDRR-03 1–16 Occurrence Handle12585742

    PubMed  Google Scholar 

  30. InstitutionalAuthorNameCenters for Disease Control and Prevention (1998) ArticleTitleRecommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recomm Rep 47 IssueIDRR-19 1–39

    Google Scholar 

  31. J Bukh RH Purcell RH Miller (1993) ArticleTitleAt least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide Proc Natl Acad Sci USA 90 8234–8 Occurrence Handle8396266 Occurrence Handle10.1073/pnas.90.17.8234 Occurrence Handle1:CAS:528:DyaK2cXht1Kgtb8%3D

    Article  PubMed  CAS  Google Scholar 

  32. P Simmonds EC Holmes TA Cha SW Chan F McOmish B Irvine et al. (1993) ArticleTitleClassification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region J Gen Virol 74 IssueIDPt 11 2391–9 Occurrence Handle8245854 Occurrence Handle1:CAS:528:DyaK2cXkvFOhtA%3D%3D Occurrence Handle10.1099/0022-1317-74-11-2391

    Article  PubMed  CAS  Google Scholar 

  33. OV Nainan MJ Alter D Kruszon-Moran FX Gao G Xia G McQuillan et al. (2006) ArticleTitleHepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States Gastroenterology 131 478–84 Occurrence Handle16890602 Occurrence Handle10.1053/j.gastro.2006.06.007 Occurrence Handle1:CAS:528:DC%2BD28XpsFyksL0%3D

    Article  PubMed  CAS  Google Scholar 

  34. LM Blatt MG Mutchnick MJ Tong FM Klion E Lebovics B Freilich et al. (2000) ArticleTitleAssessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States J Viral Hepat 7 196–202 Occurrence Handle10849261 Occurrence Handle10.1046/j.1365-2893.2000.00221.x Occurrence Handle1:STN:280:DC%2BD3czgsl2hsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  35. MH Nguyen EB Keeffe (2005) ArticleTitlePrevalence and treatment of hepatitis C virus genotypes 4, 5, and 6 Clin Gastroenterol Hepatol 3 S97–S101 Occurrence Handle16234071 Occurrence Handle10.1016/S1542-3565(05)00711-1 Occurrence Handle1:CAS:528:DC%2BD2MXhtF2ms7zE

    Article  PubMed  CAS  Google Scholar 

  36. F Legrand-Abravanel F Nicot A Boulestin K Sandres-Saune JP Vinel L Alric et al. (2005) ArticleTitlePegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection J Med Virol 77 66–9 Occurrence Handle16032749 Occurrence Handle10.1002/jmv.20414 Occurrence Handle1:CAS:528:DC%2BD2MXps1CgsLY%3D

    Article  PubMed  CAS  Google Scholar 

  37. V Soriano M Nunez M Sanchez-Conde P Barreiro J Garcia-Samaniego L Martin-Carbonero et al. (2005) ArticleTitleResponse to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4 Antivir Ther 10 167–70 Occurrence Handle15751774 Occurrence Handle1:CAS:528:DC%2BD2MXis1Kmurk%3D

    PubMed  CAS  Google Scholar 

  38. P Simmonds (1999) ArticleTitleViral heterogeneity of the hepatitis C virus J Hepatol 31 IssueIDSuppl 1 54–60 Occurrence Handle10622561 Occurrence Handle10.1016/S0168-8278(99)80375-4

    Article  PubMed  Google Scholar 

  39. DB Smith S Pathirana F Davidson E Lawlor J Power PL Yap et al. (1997) ArticleTitleThe origin of hepatitis C virus genotypes J Gen Virol 78 IssueIDpt 2 321–8 Occurrence Handle9018053 Occurrence Handle1:CAS:528:DyaK2sXosFehtw%3D%3D

    PubMed  CAS  Google Scholar 

  40. JM Pawlotsky (2003) ArticleTitleHepatitis C virus genetic variability: pathogenic and clinical implications Clin Liver Dis 7 45–66 Occurrence Handle12691458 Occurrence Handle10.1016/S1089-3261(02)00065-X

    Article  PubMed  Google Scholar 

  41. A Löve V Molnegren AS Månsson A Smáradóttir SB Thorsteinsson A Widell (2004) ArticleTitleEvolution of hepatitis C virus variants following blood transfusion from one infected donor to several recipients: a long-term follow-up J Gen Virol 85 441–50 Occurrence Handle14769902 Occurrence Handle10.1099/vir.0.19439-0 Occurrence Handle1:CAS:528:DC%2BD2cXitVGitLY%3D

    Article  PubMed  CAS  Google Scholar 

  42. VA National Hepatitis C Program. Hepatitis C: military-related blood exposures, risk factors, VA care. Available at: http://hepatitis.va.gov/vahep?page=prtop02-va-02, Accessed 13 November 2004

  43. PC Adams MJ Arthur TD Boyer LD DeLeve AM Di Bisceglie M Hall et al. (2004) ArticleTitleScreening in liver disease: report of an AASLD clinical workshop Hepatology 39 1204–12 Occurrence Handle15122748 Occurrence Handle10.1002/hep.20169

    Article  PubMed  Google Scholar 

  44. MJ Alter EE Mast LA Moyer HS Margolis (1998) ArticleTitleHepatitis C Infect Dis Clin North Am 12 13–26 Occurrence Handle9494826 Occurrence Handle10.1016/S0891-5520(05)70405-0 Occurrence Handle1:STN:280:DyaK1c7lsF2gsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  45. National Digestive Diseases Information Clearinghouse (NDDIC). Chronic hepatitis C: current disease management. Available at: http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm. Accessed 13 November 2004

  46. JH Hoofnagle (2002) ArticleTitleCourse and outcome of hepatitis C Hepatology 36 IssueIDSuppl 1 S21–S29 Occurrence Handle12407573 Occurrence Handle10.1002/hep.1840360704

    Article  PubMed  Google Scholar 

  47. T Poynard P Bedossa P Opolon InstitutionalAuthorNamefor the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups (1997) ArticleTitleNatural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 825–32 Occurrence Handle9121257 Occurrence Handle10.1016/S0140-6736(96)07642-8 Occurrence Handle1:STN:280:DyaK2s3js1ymug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  48. GL Davis JE Albright SF Cook DM Rosenberg (2003) ArticleTitleProjecting future complications of chronic hepatitis C in the United States Liver Transpl 9 331–8 Occurrence Handle12682882 Occurrence Handle10.1053/jlts.2003.50073

    Article  PubMed  Google Scholar 

  49. TE Wiley J Brown J Chan (2002) ArticleTitleHepatitis C infection in African Americans: its natural history and histological progression Am J Gastroenterol 97 700–6 Occurrence Handle11922566 Occurrence Handle10.1111/j.1572-0241.2002.05555.x

    Article  PubMed  Google Scholar 

  50. J FleckensteIn (2004) ArticleTitleChronic hepatitis C in African Americans and other minority groups Curr Gastroenterol Rep 6 66–70 Occurrence Handle14720456 Occurrence Handle10.1007/s11894-004-0028-z

    Article  PubMed  Google Scholar 

  51. KR Reddy JH Hoofnagle MJ Tong WM Lee P Pockros EJ Heathcote et al. (1999) ArticleTitleRacial differences in responses to therapy with interferon in chronic hepatitis C. The Consensus Interferon Study Group Hepatology 30 787–93 Occurrence Handle10462387 Occurrence Handle10.1002/hep.510300319 Occurrence Handle1:CAS:528:DyaK1MXmtVSkt7c%3D

    Article  PubMed  CAS  Google Scholar 

  52. HB El-Serag AC Mason (1999) ArticleTitleRising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745–50 Occurrence Handle10072408 Occurrence Handle10.1056/NEJM199903113401001 Occurrence Handle1:STN:280:DyaK1M7ls1ensg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  53. JG McHutchison T Poynard S Pianko SC Gordon AE Reid J Dienstag et al. (2000) ArticleTitleThe impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group Gastroenterology 119 1317–23 Occurrence Handle11054390 Occurrence Handle10.1053/gast.2000.19289 Occurrence Handle1:CAS:528:DC%2BD3MXhtFKhtro%3D

    Article  PubMed  CAS  Google Scholar 

  54. LJ Jeffers W Cassidy CD Howell S Hu KR Reddy (2004) ArticleTitlePeginterferon alpha-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1 Hepatology 39 1702–8 Occurrence Handle15185312 Occurrence Handle10.1002/hep.20212 Occurrence Handle1:CAS:528:DC%2BD2cXlsVWrtrc%3D

    Article  PubMed  CAS  Google Scholar 

  55. AJ Muir JD Bornstein PG Killenberg for the (2004) ArticleTitleAtlantic Coast Hepatitis Treatment Group. Peginterferon alpha-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites N Engl J Med 350 2265–71 Occurrence Handle15163776 Occurrence Handle10.1056/NEJMoa032502 Occurrence Handle1:CAS:528:DC%2BD2cXksVehtr4%3D

    Article  PubMed  CAS  Google Scholar 

  56. Y Tanaka K Hanada M Mizokami AE Yeo JW Shih T Gojobori et al. (2002) ArticleTitleInaugural Article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Proc Natl Acad Sci USA 99 15584–9 Occurrence Handle12438687 Occurrence Handle10.1073/pnas.242608099 Occurrence Handle1:CAS:528:DC%2BD3sXjvVyl

    Article  PubMed  CAS  Google Scholar 

  57. HB El-Serag AC Mason (2000) ArticleTitleRisk factors for the rising rates of primary liver cancer in the United States Arch Intern Med 160 3227–30 Occurrence Handle11088082 Occurrence Handle10.1001/archinte.160.21.3227 Occurrence Handle1:STN:280:DC%2BD3M%2FmvFOltw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  58. S Nair KK Shiv PJ Thuluvath (2002) ArticleTitleMortality from hepatocellular and biliary cancers: changing epidemiological trends Am J Gastroenterol 97 167–71 Occurrence Handle11808943 Occurrence Handle10.1111/j.1572-0241.2002.05432.x

    Article  PubMed  Google Scholar 

  59. T Poynard MF Yuen V Ratziu CL Lai (2003) ArticleTitleViral hepatitis C Lancet 362 2095–100 Occurrence Handle14697814 Occurrence Handle10.1016/S0140-6736(03)15109-4 Occurrence Handle1:CAS:528:DC%2BD3sXpvFylsb0%3D

    Article  PubMed  CAS  Google Scholar 

  60. HK Monga MC Rodriguez-Barradas K Breaux K Khattak CL Troisi M Velez et al. (2001) ArticleTitleHepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection Clin Infect Dis 33 240–7 Occurrence Handle11418885 Occurrence Handle10.1086/321819 Occurrence Handle1:STN:280:DC%2BD3MzlslGitw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  61. K Bjoro SS Froland Z Yun HH Samdal T Haaland (1994) ArticleTitleHepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin N Engl J Med 331 1607–11 Occurrence Handle7526215 Occurrence Handle10.1056/NEJM199412153312402 Occurrence Handle1:STN:280:DyaK2M%2FlvFejsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  62. M Berenguer M Prieto A Palau JM Rayon D Carrasco FS Juan et al. (2003) ArticleTitleSevere recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis Liver Transpl 9 228–35 Occurrence Handle12619018 Occurrence Handle10.1053/jlts.2003.50029

    Article  PubMed  Google Scholar 

  63. JI Arenas JF Gallegos-Orozco T Laskus J Wilkinson A Khatib C Fasola et al. (2004) ArticleTitleHepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation J Infect Dis 189 2037–46 Occurrence Handle15143471 Occurrence Handle10.1086/386338

    Article  PubMed  Google Scholar 

  64. M Guido F Bortolotti G Leandro P Jara L Hierro J Larrauri et al. (2003) ArticleTitleFibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 98 660–3 Occurrence Handle12650803 Occurrence Handle10.1111/j.1572-0241.2003.07293.x

    Article  PubMed  Google Scholar 

  65. M Vogt T Lang G Frosner C Klingler AF Sendl A Zeller et al. (1999) ArticleTitlePrevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening N Engl J Med 341 866–70 Occurrence Handle10498458 Occurrence Handle10.1056/NEJM199909163411202 Occurrence Handle1:STN:280:DyaK1MvgsVyrtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  66. M Vogt F Mühlbauer SL Braun T Lang R Busch R Lange et al. (2004) ArticleTitlePrevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening Infection 32 134–7 Occurrence Handle15188071 Occurrence Handle10.1007/s15010-004-2209-y Occurrence Handle1:STN:280:DC%2BD2c3os12ksg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  67. G Tagariello M Gerotto P Pontisso D Belvini R Salviato P Radossi et al. (2004) ArticleTitleHepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophilia Haemophilia 10 81–6 Occurrence Handle14962225 Occurrence Handle10.1046/j.1365-2516.2003.00846.x Occurrence Handle1:STN:280:DC%2BD2c%2FntlOktA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  68. K Okuda O Yokosuka (2004) ArticleTitleNatural history of chronic hepatitis C in patients on hemodialysis: case control study with 4–23 years of follow-up World J Gastroenterol 10 2209–12 Occurrence Handle15259067

    PubMed  Google Scholar 

  69. E Kenny-Walsh for the (1999) ArticleTitleIrish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin N Engl J Med 340 1228–33 Occurrence Handle10210705 Occurrence Handle10.1056/NEJM199904223401602 Occurrence Handle1:STN:280:DyaK1M3htFyitg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  70. HE Harris ME Ramsay N Andrews KP Eldridge (2002) ArticleTitleClinical course of hepatitis C virus during the first decade of infection: cohort study BMJ 324 450–3 Occurrence Handle11859045 Occurrence Handle10.1136/bmj.324.7335.450

    Article  PubMed  Google Scholar 

  71. E Minola D Prati F Suter F Maggiolo F Caprioli A Sonzogni et al. (2002) ArticleTitleAge at infection affects the long-term outcome of transfusion-associated chronic hepatitis C Blood 99 4588–91 Occurrence Handle12036892 Occurrence Handle10.1182/blood-2001-12-0192 Occurrence Handle1:CAS:528:DC%2BD38XksFGksLY%3D

    Article  PubMed  CAS  Google Scholar 

  72. F Ramalho A Costa A Pires P Cabrita F Serejo AP Correia et al. (2000) ArticleTitleCorrelation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C Dig Dis Sci 45 182–7 Occurrence Handle10695633 Occurrence Handle10.1023/A:1005442317680 Occurrence Handle1:STN:280:DC%2BD3c7lvVWrsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  73. L Rubbia-Brandt P Fabris S Paganin G Leandro PJ Male E Giostra et al. (2004) ArticleTitleSteatosis affects chronic hepatitis C progression in a genotype specific way Gut 53 406–12 Occurrence Handle14960525 Occurrence Handle10.1136/gut.2003.018770 Occurrence Handle1:STN:280:DC%2BD2c%2FpvV2itQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  74. S Mihm A Fayyazi H Hartmann G Ramadori (1997) ArticleTitleAnalysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype Hepatology 25 735–9 Occurrence Handle9049227 Occurrence Handle10.1002/hep.510250340 Occurrence Handle1:STN:280:DyaK2s3gtFCnsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  75. M Duffy M Salemi N Sheehy AM Vandamme J Hegarty M Curry et al. (2002) ArticleTitleComparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection Virology 301 354–64 Occurrence Handle12359437 Occurrence Handle10.1006/viro.2002.1597 Occurrence Handle1:CAS:528:DC%2BD38Xnt1ymu7k%3D

    Article  PubMed  CAS  Google Scholar 

  76. U Gaud B Langer T Petropoulou HC Thomas P Karayiannis (2003) ArticleTitleChanges in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects J Med Virol 69 350–6 Occurrence Handle12526045 Occurrence Handle10.1002/jmv.10296 Occurrence Handle1:CAS:528:DC%2BD3sXhsFeqtL0%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rustgi, V. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 42, 513–521 (2007). https://doi.org/10.1007/s00535-007-2064-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-007-2064-6

Key words

Navigation